BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Physical Manifestations of Molecular Mutations in Chip-based Cance
 r Diagnostics
DTSTART:20130627T110000
DTSTAMP:20260429T125641Z
UID:9092c4bf55dc2b681f588f25f4ac84579b8981d1900f2f18ae129971
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Samir Iqbal\, University of Texas\nBio: Dr. Samir Iqbal 
 is an Assistant Professor in Department of Electrical Engineering.  He ea
 rned his doctorate from Purdue University in 2007.  After joining Univers
 ity of Texas at Arlington\, he established Nano-Bio Lab. His lab is focuse
 d on enhancing sensitivity and selectivity of diagnostics approaches\, und
 erstanding nano-bio interface issues and faithful transduction of molecula
 r interactions.  He is also affiliated with the Nanotechnology Research a
 nd Education Center and holds a courtesy appointment in the Bioengineering
  Department that is joint program with the University of Texas Southwester
 n Medical Center at Dallas. He is a senior member of IEEE\, a member of Bi
 omedical Engineering Society\, American Physical Society\, American Societ
 y of Mechanical Engineers and Biophysical Society.  He has published over
  35 journal papers and presented at many international conferences.  He r
 eceived NSF CAREER award in 2009\, was named “Recognized Professor” by
  Phi Kappa Phi in 2011 and was a nominee for President’s Award for Excel
 lence in Teaching in 2013.\nEven after decades of research\, diseases like
  cancer have high global burden in terms of healthcare costs and mortality
  rate.  Early diagnosis can result in much effective treatments and drast
 ically improved prognosis.  We are approaching cancer diagnostics at vari
 ous molecular levels and scales.  The chemical mutations (genes and prote
 ins) result into many physical properties that have not been fully explore
 d hitherto.  Abnormal changes in cells\; shape\, elasticity\, growth\, si
 ze and motility are all manifestations of molecular mechanisms that can be
  easily\, economically and rapidly used for early diagnosis along with tra
 ditional histological approaches. In the cancer elimination roadmap\, iden
 tification and quantification of biomarkers and tumor cells from blood dra
 wn during yearly physical exam can be a game-changer.
LOCATION:CO 011 https://plan.epfl.ch/?room==CO%20011
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR